Acute myeloid leukemia
What is acute myeloid leukemia?
Acute myeloid leukemia (AML) starts in the blood stem cells and develops quickly. It is the most common type of leukemia in adults.
Risks for acute leukemia
Acute leukemia includes acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML). Risks for acute leukemia include high doses of radiation and previous chemotherapy treatment.
Symptoms of leukemia
Symptoms may vary depending on whether you have an acute or chronic type of leukemia.
Diagnosis of leukemia
Tests to diagnose leukemia, such as blood tests, are done when symptoms or routine tests suggest a problem.
Stages of acute myeloid leukemia
The stage describes how much cancer is in the body. Acute myeloid leukemia (AML) is described as untreated, active disease, in remission, measurable residual disease (MRD), relapsed or refractory.
Disease progression of acute myeloid leukemia
Cancer cells can spread from where they start to other parts of the body. Acute myeloid leukemia (AML) is often widespread when it is found.
Prognosis and survival for acute myeloid leukemia
Prognosis estimates the outcome for acute myeloid leukemia (AML). It depends on many factors including subtype, chromosome changes and your age.
Treatments for acute myeloid leukemia
Chemotherapy is the main treatment for acute myeloid leukemia (AML). Targeted therapy and a stem cell transplant may also be used.
Supportive care for leukemia
Supportive care helps people meet the physical, practical, emotional and spiritual challenges of leukemia.
Acute myeloid leukemia statistics
Cancer statistics tell us how many people in Canada are diagnosed with and die from acute myeloid leukemia (AML) cancer in a certain time frame.
Your trusted source for accurate cancer information
With just $5 from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.
We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.
If everyone reading this gave just $5, we could achieve our goal this month to fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.